Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (101-110 of 238) with videos related to

Pageof 24
Sort By:
Blood|April 20, 2018
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapyTheodore W Laetsch, Shannon L Maude, Michael C Milone, et al.
Blood|June 17, 2009
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313Michael A Pulsipher, Kenneth M Boucher, Donna Wall, et al.
Cancer Immunology Research|February 25, 2014
iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo Hamid Bassiri, Rupali Das, Peng Guan, et al.
Pediatric Blood & Cancer|June 7, 2018
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access programNancy A Kernan, Paul G Richardson, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Will post-transplantation cell therapies for pediatric patients become standard of care?Arjan C Lankester, Franco Locatelli, Peter Bader, et al.
Journal of Cancer Research and Clinical Oncology|July 1, 2022
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphomaPengcheng He, Haibo Liu, Bryan Zimdahl, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Blood|September 11, 2007
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) studyHaydar Frangoul, Eneida R Nemecek, Dean Billheimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy StudiesYimei Li, Wei-Ting Hwang, Shannon L Maude, et al.
Molecular and Cellular Biology|August 15, 2018
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic ReticulumAsen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Pageof 24

Showing results (101-110 of 238) with videos related to

Sort By:
Pageof 24
Blood|April 20, 2018
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapyTheodore W Laetsch, Shannon L Maude, Michael C Milone, et al.
Blood|June 17, 2009
Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313Michael A Pulsipher, Kenneth M Boucher, Donna Wall, et al.
Cancer Immunology Research|February 25, 2014
iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo Hamid Bassiri, Rupali Das, Peng Guan, et al.
Pediatric Blood & Cancer|June 7, 2018
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome following nontransplant-associated chemotherapy: Final results from a post hoc analysis of data from an expanded-access programNancy A Kernan, Paul G Richardson, Angela R Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Will post-transplantation cell therapies for pediatric patients become standard of care?Arjan C Lankester, Franco Locatelli, Peter Bader, et al.
Journal of Cancer Research and Clinical Oncology|July 1, 2022
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphomaPengcheng He, Haibo Liu, Bryan Zimdahl, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Blood|September 11, 2007
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) studyHaydar Frangoul, Eneida R Nemecek, Dean Billheimer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy StudiesYimei Li, Wei-Ting Hwang, Shannon L Maude, et al.
Molecular and Cellular Biology|August 15, 2018
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic ReticulumAsen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Pageof 24